Fukushima Kenjiro, Kanemoto Hideyuki, Ohno Koichi, Takahashi Masashi, Nakashima Ko, Fujino Yasuhito, Uchida Kazuyuki, Fujiwara Reina, Nishimura Ryohei, Tsujimoto Hajime
Department of Veterinary Internal Medicine, University of Tokyo, Tokyo, Japan.
Vet Radiol Ultrasound. 2012 May-Jun;53(3):252-7. doi: 10.1111/j.1740-8261.2011.01917.x. Epub 2012 Jan 15.
Little information is available on the relationship between computed tomography (CT) imaging findings and the pathologic diagnosis of canine hepatic tumors. Our purpose was to clarify the characteristic features of CT findings in liver tumors in dogs. Data from 33 dogs with either a hepatocellular carcinoma, n = 14, hepatocellular adenoma, n = 14, or nodular hyperplasia, n = 5 were summarized from medical records. CT features for each histologic diagnosis were characterized and analyzed statistically. Common findings in hepatocellular carcinoma included central (79%, P = 0.0030) and marginal enhancement (93%, P = 0.00043) in the arterial phase, cyst-like lesions (93%), capsule formation (93%), and hypoattenuation in the portal (86%), and equilibrium phases (93%). Hepatic adenoma was characterized by a characteristic diffuse enhancement pattern during the arterial phase (57%, P = 0.013), which was also found in nodular hyperplasia (60%), but never in hepatocellular carcinoma. Nodular hyperplasia was less likely to have a capsule structure (20%, P = 0.0087). Mass size was significantly smaller in nodular hyperplasia than in hepatocellular carcinoma and hepatic adenoma (P = 0.0033 and 0.038, respectively). Hyperattenuation in the arterial and the portal phase i.e. contrast retention, was more frequent in hepatic adenoma than in the other groups (P = 0.037 and 0.037, respectively). Nodular hyperplasia was more frequently isoattenuating in the equilibrium phase (P = 0.043).
关于计算机断层扫描(CT)成像结果与犬肝脏肿瘤病理诊断之间的关系,目前可用信息较少。我们的目的是阐明犬肝脏肿瘤CT表现的特征。从病历中总结了33只患有肝细胞癌(n = 14)、肝细胞腺瘤(n = 14)或结节性增生(n = 5)的犬的数据。对每种组织学诊断的CT特征进行了表征并进行了统计分析。肝细胞癌的常见表现包括动脉期中央强化(79%,P = 0.0030)和边缘强化(93%,P = 0.00043)、囊样病变(93%)、包膜形成(93%)以及门静脉期(86%)和平衡期(93%)的低密度。肝细胞腺瘤的特征是在动脉期具有特征性的弥漫性强化模式(57%,P = 0.013),结节性增生中也有此表现(60%),但肝细胞癌中从未出现。结节性增生形成包膜结构的可能性较小(20%,P = 0.0087)。结节性增生的肿块大小明显小于肝细胞癌和肝细胞腺瘤(分别为P = 0.0033和0.038)。肝细胞腺瘤在动脉期和门静脉期的高密度即造影剂滞留比其他组更常见(分别为P = 0.037和0.037)。结节性增生在平衡期更常呈等密度(P = 0.043)。